1-8 of 8
Si-Tien Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Introduction of Glofitamab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) after ≥2 Lines of Systemic Therapy Results in Cost Savings to the Healthcare System Based on a United States Budget Impact Analysis

Zahra Mahmoudjafari, Jia Li, Eric Bercaw, Hélène Parisé, Katalin Bognar, Si-Tien Wang, Anthony Masaquel
Journal: Blood
Blood (2023) 142 (Supplement 1): 7246.
https://doi.org/10.1182/blood-2023-174218
Published: 2023
Journal Articles

Indirect Treatment Comparison of CC-486 Versus Azacitidine (AZA) As Maintenance Therapy for Acute Myeloid Leukemia (AML)

Ashley Tabah, David Huggar, Si-Tien Wang, Scott J. Johnson, Ronda Copher, PhD, Thomas O'Connell, Thomas W. Leblanc
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-136752
Published: 2020
Journal Articles

Monitoring and Treatment of Transfusional Iron Overload: Findings from an Electronic Medical Records Review Study at the Moffitt Cancer Center and Research Institute.

Leslie A Ray, PharmD, Gene A. Wetzstein, PharmD, BCOP, Si-Tien Wang, MS, Amy Guo, PhD, Caroline Korves, ScD, Bentley Clinton, BA, Robert Wei, BA, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2010) 116 (21): 1503.
https://doi.org/10.1182/blood.V116.21.1503.1503
Published: 2010
Journal Articles

The Cost-Effectiveness of Bortezomib Plus Melphalan and Prednisone Versus Lenalidomide Plus Melphalan and Prednisone with Continuous Lenalidomide Maintenance Treatment for the Initial Treatment of Multiple Myeloma In the United States

Si-Tien Wang, MS, Hui Huang, PhD, MBA, Abbie Ba-Mancini, BS, MBA, Hongliang Shi, MS, Kristina Chen, MS, Caroline Korves, ScD, Ravinder Dhawan, PhD, Andrew Cakana, FRCPath, MD, Helgi van de Velde, Dixie-Lee W. Esseltine, MD, FRCPC, Mei S. Duh, ScD, MPH
Journal: Blood
Blood (2010) 116 (21): 2563.
https://doi.org/10.1182/blood.V116.21.2563.2563
Published: 2010
Journal Articles

The Cost-Effectiveness of Bortezomib for the Initial Treatment of Multiple Myeloma in the United States.

Si-Tien Wang, Hui Huang, Hongliang Shi, Mei Sheng Duh, Kristina Chen, Eva Chang, Caroline Korves, Ravinder Dhawan, Andrew Cakana, Helgi van de Velde, Dixie-Lee Esseltine, Louis Garrison
Journal: Blood
Blood (2009) 114 (22): 1379.
https://doi.org/10.1182/blood.V114.22.1379.1379
Published: 2009
Journal Articles

Costs to Medicare of Treating Chronic Lymphocytic Leukemia Patients with Alemtuzumab.

Marie-Hélène Lafeuille, MA, Francis Vekeman, MA, Matthew Kerrigan, PhD, Si-Tien Wang, Mei Duh, MPH, ScD
Journal: Blood
Blood (2009) 114 (22): 2477.
https://doi.org/10.1182/blood.V114.22.2477.2477
Published: 2009
Journal Articles

Efficacy and Safety of Nilotinib in Elderly Patients with Imatinib-Resistant or -;Intolerant Chronic Myeloid Leukemia (CML) in Chronic Phase (CP): A Sub-Analysis of the ENACT (Expanding Nilotinib Access in Clinical Trials) Study.

Philipp D. le Coutre, MD, Anna Turkina, Dong-Wook Kim, MD, PhD, Bernadeta Ceglarek, Giuliana Alimena, Haifa Kathrin Al-Ali, MD, Zhixiang Shen, Saengsuree Jootar, MD, Graeme Smith, MD, Carmino Antonio De Souza, MD, PhD, Pedro Enrique Dorlhiac-Llacer, David A Rizzieri, MD, Tomasz Szczudlo, MD, Myriam Berton, Jim Wang, PhD, Si-Tien Wang, Franck Emmanuel Nicolini, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3286.
https://doi.org/10.1182/blood.V114.22.3286.3286
Published: 2009
Journal Articles

An Economic Evaluation of Bortezomib-Based Induction Therapy in Double Transplant Protocols for Newly Diagnosed Multiple Myeloma Patients

Si-Tien Wang, BA, MS, Mei Sheng Duh, MPH, ScD, Hui Huang, PhD, MBA, Leigh Ann White, PhD, Eva Chang, MPH, Dixie-Lee Esseltine, MD, Jing L. Marantz, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 2386.
https://doi.org/10.1182/blood.V112.11.2386.2386
Published: 2008